Click for more products.
No produts were found.

Ambroxol 30mg tablets 30

Size chart
Women's clothing size
Euro 32/34 36 38 40
USA 0/2 4 6 8
Bust(in) 31-32 33 34 36
Bust(cm) 80.5-82.5 84.5 87 92
Waist(in) 24-25 26 27 29
Waist(cm) 62.5-64.5 66.5 69 74
Hips(in) 34-35 36 37 39
Hips(cm) 87.5-89.5 91.5 94 99
How To Measure Your Bust

With your arms relaxed at your sides, measure around the fullest part of your chest.

How To Measure Your Waist

Measure around the narrowest part of your natural waist, generally around the belly button. To ensure a comfortable fit, keep one finger between the measuring tape and your body.

Volume discounts

Quantity Unit discount You Save
2 25% $7.68
3 35% $16.13
4 40% $24.58
 Customer ratings and reviews
Nobody has posted a review yet
in this language
Add to compare0
Add to wishlist





30 mg.


Active ingredient: Ambroxol hydrochloride 30 mg.

Excipients: lactose monohydrate - 171 mg, corn starch - 36 mg, magnesium stearate - 1.2 mg, colloidal silicon dioxide (Aerosil) - 1.8 mg.

Pharmacological properties

Mucolytic and expectorant agent, is an active N-demethylated metabolite of bromhexine. It has a secretory, secretolytic and expectorant effect. It stimulates serous cells of the bronchial mucosa, increases the motor activity of the ciliated epithelium by acting on type 2 pneumocytes in the alveoli and Clara cells in the bronchioles, enhances the formation of endogenous surfactant - a surfactant that ensures the sliding of bronchial secretions in the airway lumen.

Ambroxol increases the proportion of the serous component in bronchial secretions, improving its structure and helping to reduce the viscosity and dilute sputum; as a result of this, mucociliary transport is improved and the excretion of sputum from the bronchial tree is facilitated.

When taking Ambroxol orally, the effect, on average, occurs after 30 minutes and lasts 6-12 hours, depending on the single dose.

Indications for use

Diseases of the respiratory tract, accompanied by the release of viscous sputum and difficulty in sputum discharge: acute and chronic bronchitis; pneumonia; bronchial asthma; bronchiectasis; COPD.

  • Hypersensitivity to ambroxol or auxiliary components of drugs;
  • I trimester of pregnancy; lactation period (breastfeeding);
  • children under 6 years of age (for tablets);
  • children under 12 years of age (for long-acting dosage forms).

With care

Impaired bronchial motility and increased mucus secretion (for example, in the rare syndrome of motionless cilia); renal impairment and / or severe hepatic impairment; peptic ulcer and duodenal ulcer (including history); II and III trimesters of pregnancy; children under 2 years of age (oral solution; only as directed by a doctor).

Pregnancy and lactation use

Ambroxol is contraindicated in the first trimester of pregnancy. If it is necessary to use it in the II and III trimesters, the potential benefits of therapy for the mother and the possible risk to the fetus should be assessed.

If it is necessary to use Ambroxol during lactation, the issue of stopping breastfeeding should be resolved.

Application for violations of liver function

Use with caution in severe liver failure.

Application for impaired renal function

Use with caution in renal failure.

Use in children

Application is possible in accordance with the dosage regimen and in dosage forms intended for this category of patients.

Use in the elderly

The drug is approved for use in elderly patients.

Special instructions

Ambroxol should not be taken concurrently with antitussive drugs that can inhibit the cough reflex, for example, with codeine. this can make it difficult to remove liquefied phlegm from the bronchi.

Ambroxol should be used with caution in patients with a weakened cough reflex or impaired mucociliary transport due to the possibility of sputum accumulation.

Patients taking ambroxol are not recommended to perform breathing exercises due to difficulty in sputum discharge. In critically ill patients, aspiration of liquefied sputum should be performed.

Do not take Ambroxol just before bed.

In patients with bronchial asthma, ambroxol may aggravate the cough.

Patients with severe skin lesions - Stevens-Johnson syndrome or toxic epidermal necrolysis - may experience a flu-like condition in the early phase: fever, body pains, rhinitis, cough, pharyngitis. In symptomatic therapy, mucolytic agents such as ambroxol hydrochloride may be misused.

Drug Interactions

Antitussives (for example, codeine) - due to suppression of the cough reflex, sputum may accumulate in the lumen of the respiratory tract with difficulty in removing it (simultaneous use is not recommended).

Amoxicillin, doxycycline, cefuroxime, erythromycin - increased penetration of antibiotics into bronchial secretions.

Method of administration and dosage


Children from 6 to 12 years old: 15 mg (1/2 tablet) 2-3 times a day.

Adults and children over 12 years old: 30 mg (1 tablet) 3 times a day.

If necessary, to enhance the therapeutic effect, you can prescribe 60 mg (2 tablets) 2 times a day. The drug is taken with liquid. You can take the tablets with or without food.

If the symptoms of the disease persist within 4-5 days from the start of admission, it is recommended to consult a doctor.

Side Effects

Allergic reactions: rarely - skin rash, urticaria, exanthema, swelling of the face, shortness of breath, itching, fever; frequency unknown - anaphylactic reactions including anaphylactic shock, angioedema, pruritus, allergic contact dermatitis.

From the digestive system: often - nausea; infrequently - vomiting, diarrhea, indigestion, abdominal pain.

From the nervous system: often - dysgeusia.

Skin and subcutaneous tissue disorders: very rarely - toxic epidermal necrolysis (Lyell's syndrome), Stevens-Johnson syndrome; frequency unknown - acute generalized eczematous pustulosis.

From the respiratory system: often - decreased sensitivity in the mouth or pharynx; rarely - dryness of the mucous membrane of the respiratory tract, rhinorrhea; in isolated cases - dryness of the mucous membrane of the pharynx.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Conditions of dispensing from pharmacies

Without a prescription.

Read more
Product Details

Data sheet

Dosage form
30 mg
No comments

Be the first to write your review !



Click for more products.
No produts were found.

Create a free account to save loved items.

Sign in

Create a free account to use wishlists.

Sign in